Press Release
Press Release
According to a new report by EMR titled, ‘The global precision medicine market size reached a value of USD 81.31 billion in 2023. The market is anticipated to grow at a CAGR of 12.3% during the forecast period of 2024-2032, reaching a value of USD 230.96 billion by 2032. The growth can be attributed to the increased demand for precision medicine, advancements in sequencing technologies, and the growing application of precision medicine in various fields.
In the past few years, research into the field of medicine has brought precision medicine to greater attention. Rather than having a drug which fits all, precision medicine takes into consideration the profile of specific individuals and their genetic history. This approach reduces the need for invasive procedures and costly tests, which in turn is expected to cut costs and become less cumbersome for the patient as well. This has resulted in greater awareness and greater demand for precision medicine. This has especially been made possible because complementary fields like bio-informatics and genomics have also been growing at fast paces.
Precision medicine has seen a large market share in developed markets such as North America and Europe, where robust medical systems and research facilities already existed in place to capture the demand. It is, however, expected to grow at a high growth rate in Asia Pacific where centres of high population, increasing research into medicine as well as a rising middle class with better disposable income looks forward to better forms of healthcare.
Quest Diagnostics (NYSE: DGX) is one of the major companies in the field of precision medicine which has invested considerably across the world in research in this field. Like Quest Diagnostics, most companies maintain a large database of patients and their genetic profiles across the world to gain a large sample space to get better results. Such research is expected to improve the efficacy of precision medicine against diseases, which will increase the popularity of precision medicine in the coming years.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major players in the global precision medicine market are Siemens Healthcare GmbH, Janssen Pharmaceutica N.V., Quests Diagnostics Incorporated, F. Hoffmann-La Roche Ltd., and Myriad Genetics Inc., among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.